Adenocyte is an Israeli medical technology company founded in 2018 that develops LINFU, a patented method using low-intensity non-focused ultrasound to increase the exfoliation of epithelial cells and improve cytology samples for early detection of pancreatic dysplasia and cancer. Its labs are in Haifa and Jerusalem, with clinical development at the Technion and US registry studies run by its affiliate Adenocyte LLC.